Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant”

1,100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,100 results

Testing effectiveness (Phase 2)Study completedNCT02787005
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Merck Sharp & Dohme LLC 388
Testing effectiveness (Phase 2)Ended earlyNCT01420861
What this trial is testing

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
GTx 18
Large-scale testing (Phase 3)Study completedNCT04056754
What this trial is testing

Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 268
Testing effectiveness (Phase 2)Looking for participantsNCT07363486
What this trial is testing

Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 9
Post-approval studies (Phase 4)Looking for participantsNCT05919329
What this trial is testing

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Who this might be right for
Castration Resistant Prostate CancerCastration Sensitive Prostate CancerProstate Adenocarcinoma
OHSU Knight Cancer Institute 80
Testing effectiveness (Phase 2)Looking for participantsNCT04704505
What this trial is testing

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Study completedNCT03652493
What this trial is testing

Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

Who this might be right for
Castration-resistant Prostate CancerMetastasis
Centre Francois Baclesse 16
Testing effectiveness (Phase 2)Study completedNCT00473512
What this trial is testing

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT04188587
What this trial is testing

177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06500247
What this trial is testing

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Qilu Hospital of Shandong University 43
Not applicableStudy completedNCT03896984
What this trial is testing

Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Bayer 346
Testing effectiveness (Phase 2)Study completedNCT04060394
What this trial is testing

Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Laekna Limited 49
Early research (Phase 1)Study completedNCT05999968
What this trial is testing

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Who this might be right for
Prostatic Neoplasms
Eli Lilly and Company 10
Early research (Phase 1)Study completedNCT04703920
What this trial is testing

Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Castration-resistant Prostate CancerMetastatic Ovarian Carcinoma+1 more
University of Michigan Rogel Cancer Center 26
Not applicableLooking for participantsNCT06321679
What this trial is testing

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
European Institute of Oncology 40
Testing effectiveness (Phase 2)Ended earlyNCT03770455
What this trial is testing

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Jodi Layton, MD 8
Early research (Phase 1)WithdrawnNCT04879589
What this trial is testing

Phase 1 Study of ATRS-2002 in Healthy Male Adults

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syneos Health
Testing effectiveness (Phase 2)Looking for participantsNCT05563558
What this trial is testing

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Who this might be right for
Prostate Cancer Metastatic
Fundacion Oncosur 42
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Load More Results